Progress and Prospects of CAR-T Therapy for the Treatment of Solid Tumors
DOI:
https://doi.org/10.54097/4y6n1x07Keywords:
CAR-T cell therapy, solid tumor treatment, immunotherapy.Abstract
CAR-T therapy utilizes cytokines, cytotoxic particles, and ligand receptors in order to eradicate malignant cells. The objective may be accomplished by either directly inducing tumor cell death or indirectly augmenting the immune response against these cells. Recent days, in treating hematological malignancies, CAR-T therapy demonstrated high efficiency and multiple successful clinical applications. However, the available literature reveals a scarcity of research regarding the impact of CAR-T therapy on solid tumors although they account for about 90% of the cancer cases in the adult population. Solid tumors present challenges to CAR-T therapy because of trafficking or infiltration issues, tumor antigen heterogeneity, and an immunosuppressive microenvironment (TME). This review aims to assess these obstacles and explore various techniques and innovative approaches developed to address these limitations. Moreover, in this review, we review the structure and mechanism of CAR-T and further discuss the potential future applications of CAR-T therapy in treating solid malignancies.
Downloads
References
Weir, Kirsten. “Engineering the Immune System to Tackle Solid Tumors.” Pennmedicine.Org, 13 Aug. 2023.
Herrick, Ashley. “Introduction to Car T-Cell Therapy Part 1: Background & Current Development Landscape > Premier Research.” Premier Research, 13 Jan. 2023.
Rafiq, Sarwish, et al. “Engineering Strategies to Overcome the Current Roadblocks in Car T Cell Therapy.” Nature News, Nature Publishing Group, 17 Dec. 2019.
Jayaraman, Jayapriya, et al. “Car-T Design: Elements and Their Synergistic Function.” CAR-T Design: Elements and Their Synergistic Function, eBioMedicine, 30 July 2020.
Sterner, Robert C., and Rosalie M. Sterner. “Car-T Cell Therapy: Current Limitations and Potential Strategies.” Nature News, Nature Publishing Group, 6 Apr. 2021.
Vidarsson, Gestur, et al. “IGG Subclasses and Allotypes: From Structure to Effector Functions.” Frontiers in Immunology, U.S. National Library of Medicine, 20 Oct. 2014.
Funfrock, Philippe. “The Structure of CAR-T Cells.” ProteoGenix, Proteoblog, 21 July 2022.
Zhang, Cheng, et al. “Engineering Car-T Cells - Biomarker Research.” BioMed Central, BioMed Central, 24 June 2017.
Benmebarek, Mohamed-Reda, et al. “Killing Mechanisms of Chimeric Antigen Receptor (CAR) T Cells.” International Journal of Molecular Sciences, U.S. National Library of Medicine, 14 Mar. 2019.
Bell, Matthew, and Stephen Gottschalk. “Engineered Cytokine Signaling to Improve Car T Cell Effector Function.” Frontiers in Immunology, U.S. National Library of Medicine, 4 June 2021.
Kleber, Martina, et al. “BCMA in Multiple Myeloma-a Promising Key to Therapy.” Journal of Clinical Medicine, U.S. National Library of Medicine, 10 Sept. 2021.
Chen, Yi-Ju, et al. “Car-T: What Is Next?” Cancers, U.S. National Library of Medicine, 21 Jan. 2023.
WebMD Editoral Contributors. “Cancer Treatment: What to Expect from Surgery, Chemo, and Radiation.” WebMD, WebMD, 2 Aug. 2022.
Amjad, Muhammad T., et al. “Cancer Chemotherapy - Statpearls - NCBI Bookshelf.” Cancer Chemotherapy, 27 Feb. 2023.
Mayo clinic. “Radiation Therapy.” Mayo Clinic, Mayo Foundation for Medical Education and Research, 20 Apr. 2023.
Daei Sorkhabi, Amin, et al. “The Current Landscape of Car T-Cell Therapy for Solid Tumors: Mechanisms, Research Progress, Challenges, and Counterstrategies.” Frontiers in Immunology, U.S. National Library of Medicine, 20 Mar. 2023.
Marofi, Faroogh, et al. “Car T Cells in Solid Tumors: Challenges and Opportunities - Stem Cell Research & Therapy.” BioMed Central, BioMed Central, 25 Jan. 2021.
Ma, Shuo, et al. “Current Progress in Car-T Cell Therapy for Solid Tumors.” International Journal of Biological Sciences, U.S. National Library of Medicine, 7 Sept. 2019.
Huang SW; Pan CM; Lin YC; Chen MC; Chen Y; Jan CI; Wu CC; Lin FY; Wang ST; Lin CY; Lin PY; Huang WH; Chiang YT; Tsai WC; Chiu YH; Lin TH; Chiu SC; Cho DY; “Bite-Secreting Car-Γδt as a Dual Targeting Strategy for the Treatment of Solid Tumors.” Advanced Science (Weinheim, Baden-Wurttemberg, Germany), U.S. National Library of Medicine, 10 June 2023.
Huang, Meijuan, et al. “Innovative Strategies to Advance Car T Cell Therapy for Solid Tumors.” American Journal of Cancer Research, U.S. National Library of Medicine, 1 July 2020.
Liu, Zaoqu, et al. “Immunosuppression in Tumor Immune Microenvironment and Its Optimization from CAR-T Cell Therapy.” Theranostics, U.S. National Library of Medicine, 29 Aug. 2022.
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Highlights in Science, Engineering and Technology
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
